Catalyst Wire Dossier Catalyst Wire Dossier

Nocturin

desmopressin · Ferring Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nocturin, covering 2011-04-11 to 2011-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

See pricing